CVML advised AB Science on a EUR 34.0 million private placement of new ordinary shares. The shares were subscribed by qualified investors specialized in the pharmaceutical or biotechnological sector. The placement was done in two tranches, with a first settlement delivery of the newly issued shares on March 29, 2017, and a second settlement delivery on April 4, 2017. The…

CERBA HEALTHCARE supports the development of MENALABS, a group of medical biology laboratories based in the United Arab Emirates. CERBA HEALTHCARE, which has its biggest presence in Europe, followed by the USA, Australia, South Africa and China, strengthens its international positions in a region that is experiencing strong growth, with the help of a seasoned management and medical team, in…

CVML advised AB Science on a EUR 12.0 million private placement of new shares with subscription warrants attached. The securities were subscribed by funds managed by RA Capital Management, a US based healthcare focused asset manager. The private placement was managed by Chardan Capital Markets as Bookrunner and Lead Placement Agent. The CVML team included Paris-based partners Pierre Treille and…

Article published in Option Droit & Affaires on 6 March 2013.